Cleared Traditional

K023286 - CARECOMPANION PATIENT STATION/CARECOMPANION PATIENT STATION

K023286 is an FDA 510(k) clearance for CARECOMPANION PATIENT STATION/CARECOMPA..., manufactured by Neptec Design Group, Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 212-day FDA review.

K023286 · Neptec Design Group, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2003
Decision
212d
Days
Class 2
Risk

K023286 is an FDA 510(k) clearance for the CARECOMPANION PATIENT STATION/CARECOMPANION PATIENT STATION. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Neptec Design Group, Ltd. (Kanata, Ontario, CA). The FDA issued a Cleared decision on May 2, 2003 after a review of 212 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Neptec Design Group, Ltd. devices

FDA 510(k) Submission Details - K023286

510(k) Number K023286 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2002
Decision Date May 02, 2003
Days to Decision 212 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 125d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 905
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K023286.
HL888RA
K031835 · Health & Life Co., Ltd. · Jul 2003
AMBULATORY BLOOD PRESSURE (ABP) 92506 REPORT MANAGEMENT SYSTEM (RMS), MODEL 92506
K031479 · Datex-Ohmeda, Inc. · Jun 2003
AVITA BPM1 SERIES (WRIST TYPE) BLOOD PRESSURE METER (OR MONITOR)
K030230 · Avita Corporation · May 2003
HL888JF
K030541 · Health & Life Co., Ltd. · Apr 2003
HL888HM
K030499 · Health & Life Co., Ltd. · Apr 2003
HL888HA
K030498 · Health & Life Co., Ltd. · Apr 2003